Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9647718
Reference Type
Journal Article
Title
Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study
Author(s)
Erdogan, MF; Gürsoy, A; Ozgen, G; Cakir, M; Bayram, F; Ersoy, R; Algün, E; Cetinarslan, B; Cömlekçi, A; Kadioglu, P; Balci, MK; Yetkin, I; Kabalak, T; Erdogan, G
Year
2005
Is Peer Reviewed?
Yes
Journal
Journal of Endocrinological Investigation
ISSN:
0391-4097
EISSN:
1720-8386
Volume
28
Issue
9
Page Numbers
806-809
Language
English
PMID
16370559
DOI
10.1007/BF03347570
Abstract
OBJECTIVE:
Medullary thyroid carcinoma (MTC) frequently occurs in a sporadic form, but a substantial number of cases are hereditary and appear as part of the multiple endocrine neoplasia type 2 (MEN2) syndromes. Germline mutations in ret proto-oncogene have been shown to be the underlying cause of MEN2 syndromes.
DESIGN:
We carried out a multi-center study that aimed to perform mutational analysis of so called sporadic MTC patients.
METHODS:
Fifty-six MTC patients verified by histopathologic examination were subjected to genetic analysis. Exon 10, 11, 13, 14, 15 and 16 of the ret gene were analyzed by DNA sequencing and restriction enzyme digestion method.
RESULTS:
Among 56 apparently sporadic MTC patients, we identified 6 (10.7%) ret germline mutation carriers. Three individuals carried mutations at codon 634 in exon 11, one at codon 618 in exon 10, and two at codon 804 in exon 14. Identification of the predisposition gene mutation has allowed DNA-based strategy for direct mutation detection in patients with apparently sporadic MTCs. A substantial number of patients with apparently sporadic MTC carried germline mutations and 50% of their first degree relatives are expected to have or to develop MTC and/or other endocrine tumors.
CONCLUSIONS:
These results indicate the importance of careful genetic surveillance of any patient with apparently sporadic MTCs.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity